Search for: "Anda Inc." Results 101 - 120 of 961
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Sep 2014, 9:41 pm by Patent Docs
Allergan had asserted its 7,351,404 patent (the '404 patent) and Duke asserted its 7,388,029 patent (the '029 patent) after Apotex filed an ANDA for a generic version of Allergan's Latisse®, an ophthalmic solution comprising bimatoprost (a prostaglandin F-2-alpha ("PGF") analog) as the active ingredient. [read post]
14 Oct 2015, 9:59 pm by Patent Docs
Noonan -- Last week the Federal Circuit affirmed a District Court's finding of invalidity and non-infringement in ANDA litigation between Spectrum Pharmaceuticals and Sandoz. [read post]
25 Mar 2014, 9:59 pm by Patent Docs
The case involved BARR's filing of an ANDA (as the second filer) for a generic version of "Alcon's glaucoma and ocular hypertension drug Travatan Z®, which contains travoprost [a type PGF2α prostaglandin analog], the synthetic prostaglandin fluprostenol isopropyl ester." [read post]
6 May 2011, 4:54 pm by Pilar G. Kraman
May 5, 2011), an ANDA case, Cephalon filed a motion to stay pending its appeal of related litigation. [read post]
19 Oct 2010, 7:31 am by Phil
The following is excerpted from an October 18, 2010 Somaxon press release published at Business Wire: Somaxon Pharmaceuticals, Inc. [read post]
14 Oct 2007, 7:52 pm
Medtronic, Inc., 496 U.S. 661, 678 (1990), by statutory command it is infringement nonetheless. [read post]
14 Feb 2017, 9:13 pm by Patent Docs
Noonan -- The Federal Circuit, in its third opinion involving ANDA litigation between these parties over Shire's LIALDA® (mesalamine) product, has apparently brought this case to a close in generic drug maker Watson's favor, in a decision handed down last Friday. [read post]
24 Oct 2008, 11:37 am
Mylan believes that it is first to file ANDA for the product. [read post]